
I was sacked by NASA for telling TRUTH about alien mission – now I fear Mars astronauts won't come home alive
Catharine Conley, the agency's Planetary Protection Officer from 2006 to 2017, also fears SpaceX astronauts won't come home alive.
10
10
10
Conley first accused officials at the Jet Propulsion Lab (JPL) in California of failing to clean the Mars 2020 rover correctly before its launch.
Mars 2020 is Nasa's mission sent to search for samples of the Red Planet to bring home and test for evidence of past or current alien life.
The rover, Perseverance, is still crawling around the surface after landing in February 2021.
Its job is to obtain the samples which will then be collected by a future Mars Sample Return Mission.
But Conley feared any material eventually flown home could be contaminated - and the whole mission scuppered.
She claims she was suddenly removed from the position after speaking out - and suspects it was to silence her concerns.
Conley told The Sun: 'Nasa decided they didn't want to do the kind of work that I had been doing.
'They didn't want to continue with the kinds of implementation that they had been doing historically.
'That was not something I thought was a good idea, so they decided they needed someone else for the job.
"This was basic planetary protection as it had been done for the prior 50 years or so."
Mystery space rock blazing through solar system 'may be oldest comet ever seen'
Conley, who now works as a researcher, added: 'The Mars 2020 rover was cleaned in a way that was not compatible with prior levels of cleanliness, in particular regarding the amount of contamination that was getting introduced into the samples that were being collected for return.
'I pointed out that having a 0.1% chance of contaminating any individual sample, when you have 40 samples in total, comes out to a 4 per cent chance of having Earth contamination in the samples you're looking at.
'That makes it fairly difficult to be confident that you can distinguish between Earth life and Mars life.
'That was not something that the people at headquarters management wanted to hear and they took the steps that they thought were appropriate.'
10
Conley claims she had been told of staff being careless when using gloves and protective equipment.
She also claimed to have been told of staff bringing equipment into assembly rooms that was not properly cleaned, along with an 'attitude of skepticism I encountered regularly at JPL'.
Nasa states on its website that Mars 2020 Perseverance Rover remains an active mission.
It landed in February 2021 as part of Nasa's Mars Sample Return (MSR) campaign.
In January the agency said it was hoping to announce plans for the returning of samples in the second half of 2026.
But that has been thrown into doubt following Donald Trump's proposed cuts to Nasa, with MSR a casualty.
10
China is preparing to press ahead with their own plans to return Mars samples.
It has scheduled the Tianwen-3 Mars mission for launch in 2028, collecting and bringing samples back by 2031.
But Conley still fears the same problem.
She said: 'The concerns are similar. I've been looking at some of the reports that have come out about the Chinese proposed missions, and they're saying all the right things to the extent that I can obtain information.
'But it is difficult to follow up on what they are actually saying they're doing.
'I certainly had experience within my duties at Nasa of engineers saying one thing and doing something else.
'So it's difficult to know. But if other space agencies are not doing anything more than Nasa did, then I would be surprised if their contamination levels are low enough that you could detect the Mars signal underneath the background from Earth.'
Despite the cuts, Trump has proposed no savings on Nasa's plans to send astronauts to Mars in the 2030s.
Nasa's mission to Mars
Nasa hopes to send astronauts to Mars as early as the 2030s.
The space company has been working to advance its technologies in a bid to send a human crew to the Red Planet.
It would take astronauts up to nine months to reach Mars - which even at its closest is 33.9 million miles away.
Astronauts could then spend up to 500 days on the planet's surface before returning to Earth - which would take another nine months.
The crew would spend their time on the planet collecting data and assessing the planetary alignment that would allow the spacecraft to land and depart from Mars on the same orbit.
Last year, the agency completed a year-long simulated mission that saw four crew members out in a replica habitat in Houston, Texas.
They logged 378 days in the 1,700-square-foot, 3D-printed habitat called Mars Dune Alpha.
But Conley fears that doing so without a sample return mission means a gaping hole in knowledge for what astronauts will encounter.
She also questions if astronauts will be allowed home if they fall sick.
Conley added: 'Not doing a robotic sample return means we don't have detailed information about what kinds of materials the astronauts are likely to encounter, and possibly bring back to Earth, which could be quite problematic if there is something hazardous in Mars regolith, even if it's not biological.
10
10
'A question that didn't get answered during Apollo and certainly hasn't been addressed since is: if astronauts get sick after contacting Mars and we can't figure out why, should they be allowed to return?
'The fundamental problem, from my perspective, is overconfidence in thinking that we already know everything we need to know about what could happen, when we don't."
Conley also warned of Elon Musk's plans to send a manned crew to Mars through his company, SpaceX.
She added: 'SpaceX say they're planning to launch humans to Mars, but I have serious doubts about whether anyone would be alive when the spacecraft gets there since SpaceX doesn't seem to be developing long-term life support systems along with their rockets.
'Musk has made numerous claims about when he'll land humans on Mars that are distinctly implausible, at least if he wants the humans to be alive when they get there.
'Nasa is much more likely to be careful about preserving astronaut health but, ironically, seems not similarly concerned about protecting the Earth from possible Mars contamination.'
The Sun has approached Nasa for a response to Conley's allegations.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
7 hours ago
- Reuters
Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports
July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high-risk people, Bloomberg News reported on Sunday. The new late-stage study will target people who are at risk of cognitive decline and aim to slow down the emergence of symptoms or prevent them fully, the report said, citing a statement. The new pre-clinical study is the third largest late-stage trial that the company has announced for its drug trontinemab, which uses an experimental technology called brain shuttle to ferry medicine past the protective blood-brain barrier, according to the report. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently with Lilly's Alzheimer's drug Kisunla getting recommendation from the European Medicines Agency (EMA) last week. Reuters could not immediately verify the report. Roche did not immediately respond to a request for a comment. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi, and Eli Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They also carry hefty price tags and the risk of serious brain swelling and bleeding.


The Independent
10 hours ago
- The Independent
‘Fantastic Four: First Steps' scores Marvel's first $100 million box office opening of 2025
Marvel's first family has finally found box office gold. 'The Fantastic Four: First Steps,' the first film about the superheroes made under the guidance of Kevin Feige and the Walt Disney Co., earned $118 million in its first weekend in 4,125 North American theaters, according to studio estimates Sunday. That makes it the fourth biggest opening of the year, behind 'A Minecraft Movie,' 'Lilo & Stitch' and 'Superman,' and the biggest Marvel opening since 'Deadpool & Wolverine' grossed $211 million out of the gate last summer. Internationally, 'Fantastic Four' made $100 million from 52 territories, adding up to a $218 million worldwide debut. The numbers were within the range the studio was expecting. The film arrived in the wake of another big superhero reboot, James Gunn's 'Superman,' which opened three weekends ago and has already crossed $500 million globally. That film, from the other main player in comic book films, DC Studios, took second place with $24.9 million domestically. 'First Steps' is the latest attempt at bringing the superhuman family to the big screen, following lackluster performances for other versions. The film, based on the original Marvel comics, is set during the 1960s in a retro-futuristic world led by the Fantastic Four, a family of astronauts-turned-superhuman from exposure to cosmic rays during a space mission. The family is made up of Reed Richards (Pedro Pascal), who can stretch his body to incredible lengths; Sue Storm (Vanessa Kirby), who can render herself invisible; Johnny Storm (Joseph Quinn), who transforms into a fiery human torch; and Ben Grimm (Ebon Moss-Bachrach), who possesses tremendous superhuman strength with his stone-like flesh. The movie takes place four years after the family gained powers, during which Reed's inventions have transformed technology, and Sue's diplomacy has led to global peace. Both audiences and critics responded positively to the film, which currently has an 88% on Rotten Tomatoes and promising exit poll responses from opening weekend ticket buyers. An estimated 46% of audiences chose to see it on premium screens, including IMAX and other large formats. The once towering Marvel is working to rebuild audience enthusiasm for its films and characters. Its two previous offerings this year did not reach the cosmic box office heights of 'Deadpool & Wolverine," which made over $1.3 billion, or those of the 'Avengers'-era. But critically, the films have been on an upswing since the poorly reviewed 'Captain America: Brave New World,' which ultimately grossed $415 million worldwide. ' Thunderbolts," which jumpstarted the summer movie season, was better received critically but financially is capping out at just over $382 million globally. Like Deadpool and Wolverine, the Fantastic Four characters had been under the banner of 20th Century Fox for years. The studio produced two critically loathed, but decently profitable attempts in the mid-2000s with future Captain America Chris Evans as the Human Torch. In 2015, it tried again (unsuccessfully) with Michael B. Jordan and Miles Teller. They got another chance after Disney's $71 billion acquisition of Fox's entertainment assets in 2019. Top 10 movies by domestic box office With final domestic figures being released Monday, this list factors in the estimated ticket sales for Friday through Sunday at U.S. and Canadian theaters, according to Comscore: 1. 'The Fantastic Four: First Steps,' $118 million. 2. 'Superman,' $24.9 million. 3. 'Jurassic World Rebirth,' $13 million. 4. 'F1: The Movie,' $6.2 million. 5. 'Smurfs,' $5.4 million. 6. 'I Know What You Did Last Summer,' $5.1 million. 7. 'How to Train Your Dragon,' $2.8 million. 8. 'Eddington,' $1.7 million. 9. 'Saiyaara,' $1.3 million. 10. 'Oh, Hi!,' $1.1 million.


The Independent
11 hours ago
- The Independent
This fuzzy animal friend may be the key to treating schizophrenia
Llamas – likely without red pajamas – may hold the key to treating schizophrenia. The serious brain disorder causes people to interpret reality abnormally, and affects approximately 3.7 million U.S. adults between the ages of 18 to 65 years old, according to the nonprofit RTI International. But the domesticated South American woolly animal might be be able to help. French researchers said this week that they had used llama antibodies, or proteins that help to protect the immune system, to design a tiny fragment of an antibody known as a 'nanobody' that will trigger a neurotransmitter in the brain involved in regulating neural activity. Neurotransmitters are chemical molecules that carry messages or signals from one nerve cell to the next target cell, according to the Cleveland Clinic. No llamas were harmed in the study and researchers can identify nanobodies in a petri dish. In the past, llama antibodies have also proven effective in fighting Covid and other 'SARS-like' viruses. When scientists at the Institute of Functional Genomics injected the molecule into the veins or the muscles, it was able to break the blood-brain barrier and effectively reach brain receptors. The barrier is a a tightly locked layer of cells that defend your brain from harmful substances. Studying the impact of the nanobodies in two tests using mice, the researchers found that they corrected cognitive deficits that were observed. There was an improvement of cognitive function with just one shot, and a prolonged effect over one week. Clinical studies are now required to show that their findings could be a new avenue of treatment for schizophrenia. "In humans obviously we don't know [yet], but in mice yes, it is sufficient to treat most deficits of schizophrenia," molecular biologist Jean-Philippe Pin told Newsweek.. He was a co-author of the research which was published in the journal Nature. Pin said that medications currently given to schizophrenia patients "treat the symptoms well, but less the cognitive deficits." The cause of the chronic condition remains unknown, but the World Health Organization says it is thought that an interaction between genes and a range of environmental factors may be the reason. The exact prevalence of schizophrenia is difficult to measure. Some have tied cases in Canada to cannabis use. Although schizophrenia can occur at any age, people are typically diagnosed between the ages of 16 and 30. Symptoms vary from person to person. There is no cure, but it can be treated through antipsychotic medications, talk therapy, and self-management strategies, the National Alliance on Mental Illness says. The study's authors hope to add this strategy to the list. 'This research confirms the potential of nanobodies as a new therapeutic strategy for acting on the brain, with their use eventually being broadened to include the treatment of other neurological illnesses,' the institute said in a statement.